Simon T. Whiteside

3.0k total citations · 1 hit paper
17 papers, 2.6k citations indexed

About

Simon T. Whiteside is a scholar working on Cancer Research, Immunology and Molecular Biology. According to data from OpenAlex, Simon T. Whiteside has authored 17 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Simon T. Whiteside's work include NF-κB Signaling Pathways (14 papers), Immune Response and Inflammation (9 papers) and interferon and immune responses (7 papers). Simon T. Whiteside is often cited by papers focused on NF-κB Signaling Pathways (14 papers), Immune Response and Inflammation (9 papers) and interferon and immune responses (7 papers). Simon T. Whiteside collaborates with scholars based in France, United States and United Kingdom. Simon T. Whiteside's co-authors include Alain Israël, Alain Israël, Gilles Courtois, Robert Weil, Heather Kirk, Robert J. Kay, Shoji Yamaoka, Christine Bessia, Fabrice Agou and Stephen Goodbourn and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Simon T. Whiteside

17 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation

1998 931 citations Shoji Yamaoka, Gilles Courtois et al. Cell profile →

Peers

Simon T. Whiteside

IMMUN

ONCOL

EPIDE

Hengyi Zhu United States

Xiong Gao China

Jeremiah Hagler United States

Raelene J. Grumont Australia

Xuefeng Wu United States

Jeannie Q. He United States

Jacqueline W. Pierce United States

W C Greene United States

Ho Yeong Song United States

Noula Shembade United States

Hengyi Zhu United States

Simon T. Whiteside

1.5k ×0.9

1.2k ×0.8

IMMUN

1000 ×0.7

446 ×0.8

ONCOL

120 ×0.8

EPIDE

Citations per year, relative to Simon T. Whiteside Simon T. Whiteside (= 1×) peers Hengyi Zhu

Countries citing papers authored by Simon T. Whiteside

Since Specialization

Citations

This map shows the geographic impact of Simon T. Whiteside's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon T. Whiteside with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon T. Whiteside more than expected).

Fields of papers citing papers by Simon T. Whiteside

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon T. Whiteside. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon T. Whiteside. The network helps show where Simon T. Whiteside may publish in the future.

Co-authorship network of co-authors of Simon T. Whiteside

This figure shows the co-authorship network connecting the top 25 collaborators of Simon T. Whiteside. A scholar is included among the top collaborators of Simon T. Whiteside based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon T. Whiteside. Simon T. Whiteside is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Schwamborn, Klaus, Robert Weil, Gilles Courtois, Simon T. Whiteside, & Alain Israël. (2000). Phorbol Esters and Cytokines Regulate the Expression of theNEMO-related Protein, a Molecule Involved in a NF-κB-independent Pathway. Journal of Biological Chemistry. 275(30). 22780–22789. 91 indexed citations

Baumann, Bernd, Christoph K. Weber, Jakob Troppmair, et al.. (2000). Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proceedings of the National Academy of Sciences. 97(9). 4615–4620. 152 indexed citations

Mémet, Sylvie, Dhafer Laouini, Jean-Charles Epinat, et al.. (1999). IκBε-Deficient Mice: Reduction of One T Cell Precursor Subspecies and Enhanced Ig Isotype Switching and Cytokine Synthesis. The Journal of Immunology. 163(11). 5994–6005. 45 indexed citations

Mémet, Sylvie, Dhafer Laouini, Jean-Charles Epinat, et al.. (1999). IkappaBepsilon-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis.. PubMed. 163(11). 5994–6005. 48 indexed citations

Orian, Amir, Alan L. Schwartz, Alain Israël, et al.. (1999). Structural Motifs Involved in Ubiquitin-Mediated Processing of the NF-κB Precursor p105: Roles of the Glycine-Rich Region and a Downstream Ubiquitination Domain. Molecular and Cellular Biology. 19(5). 3664–3673. 99 indexed citations

Yamaoka, Shoji, Gilles Courtois, Christine Bessia, et al.. (1998). Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation. Cell. 93(7). 1231–1240. 931 indexed citations breakdown →

Whiteside, Simon T. & Alain Israël. (1997). IκB proteins: structure, function and regulation. Seminars in Cancer Biology. 8(2). 75–82. 281 indexed citations

Weil, Robert, Simon T. Whiteside, & Alain Israël. (1997). Control of NF-κB Activity by the IκBβ Inhibitor. Immunobiology. 198(1-3). 14–23. 22 indexed citations

Whiteside, Simon T.. (1997). I kappa B epsilon, a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activity. The EMBO Journal. 16(6). 1413–1426. 344 indexed citations

10.

Epinat, Jean-Charles, Simon T. Whiteside, Nancy R. Rice, & Alain Israël. (1997). Reconstitution of the NF-κB System inSaccharomyces cerevisiae for Isolation of Effectors by Phenotype Modulation. Yeast. 13(7). 599–612. 11 indexed citations

11.

Courtois, Gilles, Simon T. Whiteside, Carol Hopkins Sibley, & Alain Israël. (1997). Characterization of a Mutant Cell Line That Does Not Activate NF-κB in Response to Multiple Stimuli. Molecular and Cellular Biology. 17(3). 1441–1449. 76 indexed citations

12.

Whiteside, Simon T., et al.. (1995). N- and C-Terminal Sequences Control Degradation of MAD3/IκBα in Response to Inducers of NF-κB Activity. Molecular and Cellular Biology. 15(10). 5339–5345. 214 indexed citations

13.

Orian, Amir, Simon T. Whiteside, Alain Israël, et al.. (1995). Ubiquitin-mediated Processing of NF-κB Transcriptional Activator Precursor p105. Journal of Biological Chemistry. 270(37). 21707–21714. 134 indexed citations

14.

Whiteside, Simon T., Peter H. King, & Stephen Goodbourn. (1994). A truncated form of the IRF-2 transcription factor has the properties of a postinduction repressor of interferon-beta gene expression.. Journal of Biological Chemistry. 269(43). 27059–27065. 23 indexed citations

15.

Whiteside, Simon T. & Stephen Goodbourn. (1993). Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation. Journal of Cell Science. 104(4). 949–955. 103 indexed citations

16.

Whiteside, Simon T., et al.. (1992). Identification of novel factors that bind to the PRD I region of the human β-interferon promoter. Nucleic Acids Research. 20(7). 1531–1538. 59 indexed citations

17.

Whiteside, Simon T., et al.. (1988). Art, Education and Politics. 2(3). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact